Web Results

www.goodnewsnetwork.org/fda-approves-the-first-new-cystic-fibrosis-treatment-in-decades

Nov 3, 2019 ... The drug, Trikafta, which was developed by Vertex Pharmaceuticals, can be used to treat 90% of cystic fibrosis patients 12 years or older in ...

www.healthline.com/health/cystic-fibrosis/whats-new-cf-research

Apr 9, 2018 ... New drugs to treat the underlying cause of symptoms · ivacaftor (Kalydeco), approved in 2012 · lumacaftor/ivacaftor (Orkambi), approved in 2015 ....

www.physiciansweekly.com/cystic-fibrosis-medication-adherence

Feb 6, 2014 ... Medication Adherence in Cystic Fibrosis ... Recent research in patients with cystic fibrosis (CF) suggests that there are associations between ...

www.fiercepharma.com/pharma/sham-or-public-interest-icer-suggests-70-plus-discounts-vertex-s-cystic-fibrosis-drugs

May 4, 2018 ... ICER suggests a price cut of up to 77% would be needed for Vertex's cystic fibrosis drugs to reach cost-effectiveness. (Vertex).

respiratory-research.biomedcentral.com/articles/10.1186/s12931-019-1214-8

Dec 21, 2019 ... IB3–1 CF lung epithelial cells were treated with different Vertex (VX) drugs, digitoxin, and various drug mixtures, and ELISA assays were used ...

breathe.ersjournals.com/content/9/3/176

To inform the reader of the potential benefits for their patients of this new class of drugs. Summary The prognosis for patients with cystic fibrosis (CF) ...

www.sciencenews.org/article/new-therapies-pack-triple-drug-punch-treat-cystic-fibrosis

Oct 19, 2018 ... The new triple-drug treatment builds upon the success of an earlier drug, ivacaftor, approved in 2012 for patients who have a rarer mutation ...

www.liebertpub.com/doi/10.1089/hum.2020.137

Modified mRNAs have been used in mRNA drugs treating CF patients. Specifically, ...